Clinical updates, including trial initiations, enrollment status and data readouts and publications: Amo, Aphaia, Arrowhead, Artelo, Atsena, Baudax, Erasca, First Wave, Hillevax, Lyra, Morphic, Okyo, Omeros, Parthenon, Samsung, Trefoil, Ultimovacs, Vaccinex.

New hires and promotions in the biopharma industry, including: Alloy, Entera, Epsilogen, Finch, Immutep, Linkinvax, NRG, Oculis, Oxford Biomedica, Purple, Systimmune, Xencor.

New hires and promotions in the biopharma industry in Asia-Pacific, including: Immvira, Lianbio.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Affamed, Apellis, Biosyngen, BMS, Carsgen, CSL, Daiichi Sankyo, H. Lundbeck, Hanchorbio, Huidagene, Hutchmed, Innocare, Otsuka.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Acadia, Amgen, Astellas, Daewoong, Direct, Everest Medicines, Keyuan Xinhua, LG Chem, Neuren, Sandoz, Shanghai Pharma, Sygnature Discovery, Twist, Zydus.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Arch, Axcella, Beigene, Cantex, Gritstone, Immutep, Junshi, Relief, Shionogi.

Biopharmas in Asia-Pacific raising money in public or private financings: Pharmaessentia.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carl Zeiss Meditec, Insulet, Proprio.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Autism Analytica, Avenda, Click, Concertai, Cryoport, Limber Prosthetics, Nevro, Pathai, Quadrant Biosciences, Siemens, Siemens Healthineers, Trinity Biotech.